![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Hyperplasia - 271 Studies Found
Active, not recruiting |
: A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease : Multicentric Castleman's Disease : 2009-11-30 :
|
Withdrawn |
: Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease : Giant Lymph Node Hyperplasia : 2006-08-08 : Drug: Valganciclovir valganciclovir open label, two 450mg tablets orally, twice a day |
Recruiting |
: Tocilizumab for KSHV-Associated Multicentric Castleman Disease :
|
Recruiting |
: TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial : Multicentric Castleman Disease : 2017-01-31 : Drug: Thalidomide, cyclophosphamide and prednisone |
Terminated |
: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy :
: 2005-08-04 : Drug: Rituximab |
Recruiting |
: Unlock the Cell: Castleman's Disease Flow Cytometry Study :
|
Recruiting |
: Castleman Disease Collaborative Network Biobank :
|
Completed |
: A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease :
|
Withdrawn |
: Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas :
|